MFG
FLGT icon

Mendota Financial Group’s Fulgent Genetics FLGT Stock Holding History

Mendota Financial Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$22 – 677
2024
Q3 		$22 Buy
+1
New +$22 ﹤0.01% 1181
2023
Q4 		– Sell
-415
Closed -$11.1K – 386
2023
Q3 		$11.1K Sell
415
-300
-42% -$10.2K 0.01% 191
2023
Q2 		$26.5K Sell
715
-1,470
-67% -$51.2K 0.03% 162
2023
Q1 		$136K Buy
2,185
+1,470
+206% +$47.3K 0.14% 65
2022
Q4 		$21.3K Buy
+715
New +$25.6K 0.03% 177

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mendota Financial Group's FLGT Position: Q4 2024 in Review

Mendota Financial Group sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 1 share — an estimated $22 sold.

Mendota Financial Group first reported a position in FLGT in Q4 2022 and held it in 5 quarters. The position peaked at $136K in Q1 2023. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Mendota Financial Group reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Mendota Financial Group sold 1 Fulgent Genetics share in Q4 2024, an estimated $22.
  • Mendota Financial Group first reported a position in Fulgent Genetics in Q4 2022 and held it in 5 quarters.
  • Mendota Financial Group's Fulgent Genetics position peaked at $136K in Q1 2023.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.